Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of folli...

Por Greil, R, Gattringer, C, Schulz, T, Knapp, W, Radaskiewicz, T, Dierich, M P, Huber, H
Publicado em 1986

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas

Por Krugmann, J, Tzankov, A, Dirnhofer, S, Fend, F, Greil, R, Siebert, R, Erdel, M
Publicado em 2004

Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leuka...

Por Stauder, R, Greil, R, Schulz, T F, Thaler, J, Gattringer, C, Radaskiewicz, T, Dierich, M P, Huber, H
Publicado em 1989

APOBEC3 signature mutations in chronic lymphocytic leukemia

Por Rebhandl, S, Huemer, M, Gassner, F J, Zaborsky, N, Hebenstreit, D, Catakovic, K, Grössinger, E M, Greil, R, Geisberger, R
Publicado em 2014

Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia

Por Kern, D, Regl, G, Hofbauer, S W, Altenhofer, P, Achatz, G, Dlugosz, A, Schnidar, H, Greil, R, Hartmann, T N, Aberger, F
Publicado no Oncogene (2015)

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

Por Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Publicado no Br J Cancer (2015)

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients

Por Troppan, K T, Schlick, K, Deutsch, A, Melchardt, T, Egle, A, Stojakovic, T, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Pichler, M
Publicado em 2014

Gastric cancer cell lines lack Fas ligand (FasL) expression but kill T cells via a FasL independent pathway

Por TINHOFER, I, WYKYPIEL, H, MARSCHITZ, I, HENN, T, GREIL;, R, BENNETT, M, O'CONNELL, J, ROCHE, D, BRADY, C, KELLY, J, COLLINS, J, SHANAHAN, F, O'SULLIVAN, G
Publicado em 2000

CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model

Por Kocher, T, Asslaber, D, Zaborsky, N, Flenady, S, Denk, U, Reinthaler, P, Ablinger, M, Geisberger, R, Bauer, J W, Seiffert, M, Hartmann, T N, Greil, R, Egle, A, Piñón Hofbauer, J
Publicado no Leukemia (2016)

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the...

Por Gnant, M, Pfeiler, G, Stöger, H, Mlineritsch, B, Fitzal, F, Balic, M, Kwasny, W, Seifert, M, Stierer, M, Dubsky, P, Greil, R, Steger, G, Samonigg, H, Fesl, C, Jakesz, R
Publicado em 2013

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

Por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado em 2010

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

Por Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J
Publicado em 2007

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

Por Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Publicado no Br J Cancer (2014)

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

Por Ludwig, H, Weisel, K, Petrucci, M T, Leleu, X, Cafro, A M, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauléon, S, Dümmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M
Publicado no Leukemia (2017)

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer

Por Dubsky, P., Filipits, M., Jakesz, R., Rudas, M., Singer, C. F., Greil, R., Dietze, O., Luisser, I., Klug, E., Sedivy, R., Bachner, M., Mayr, D., Schmidt, M., Gehrmann, M. C., Petry, C., Weber, K. E., Kronenwett, R., Brase, J. C., Gnant, M.
Publicado em 2013

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the AB...

Por Pfeiler, G, Stöger, H, Dubsky, P, Mlineritsch, B, Singer, C, Balic, M, Fitzal, F, Moik, M, Kwasny, W, Selim, U, Renner, K, Ploner, F, Steger, G G, Seifert, M, Hofbauer, F, Sandbichler, P, Samonigg, H, Jakesz, R, Greil, R, Fesl, C, Gnant, M
Publicado em 2013

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients

Por Dubsky, P, Brase, J C, Jakesz, R, Rudas, M, Singer, C F, Greil, R, Dietze, O, Luisser, I, Klug, E, Sedivy, R, Bachner, M, Mayr, D, Schmidt, M, Gehrmann, M C, Petry, C, Weber, K E, Fisch, K, Kronenwett, R, Gnant, M, Filipits, M
Publicado em 2013